Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET FORECAST 2022-2030

NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET FORECAST 2022-2030

The North America contrast enhanced ultrasound market is set to propel with a 5.36% CAGR by 2030, and is expected to be valued at $884.85 million during the assessment period, 2022-2030.

NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET FORECAST 2022-2030

North America Contrast Enhanced Ultrasound Market by Product (Equipment, Contrast Agent) Market by Type (Non-targeted, Targeted) Market by End-user (Hospitals, Clinics, Ambulatory Diagnostic Centers) by Geography

Request free sample

The North America contrast enhanced ultrasound market is set to propel with a 5.36% CAGR by 2030, and is expected to be valued at $884.85 million during the assessment period, 2022-2030.

In North America, contrast-enhanced ultrasound is largely used in abdominal and cardiac imaging. With recent approval to characterize liver lesions, contrast-enhanced ultrasound imaging is gaining more traction. Also, rising cases of numerous health conditions and chronic illnesses and the urgency for early detection and diagnosis will further propel the studied market towards growth. Moreover, a rising number of training and education programs for radiologists and sonographers regarding diagnostic & therapeutic use of contrast-enhanced ultrasound is expected to boost the region’s growth over the forecast period.

North America Contrast Enhanced Ultrasound Market

To know more about this report, request a free sample copy

The North America contrast enhanced ultrasound market growth evaluation entails the study of the United States and Canada. The United States contrast-enhanced ultrasound market is anticipated to grow over the forecast year due to increasing healthcare providers’ awareness of ultrasound devices’ safety and diagnostic effectiveness. The nation has well-established medical codes, payment procedures, and coverage regulations for ultrasound services in hospitals, clinics, and ambulatory centers.

Additionally, general practitioners and family doctors are reimbursed for using ultrasounds in their offices. The number of ultrasound procedures has increased in the United States. The prevalence of inflammatory bowel disorders (IBD) and cardiovascular illness is predicted to increase, increasing the demand for contrast-enhanced ultrasonography nationwide. According to the America College of Cardiology, 840,768 deaths occurred in the United States due to cardiovascular disorders in 2016, while the country also had a high age-standardized prevalence rate of 464·5 every 100,000 for IBD in 2017.

The North America contrast enhanced ultrasound market analysis includes segmentation by end-user, product, and type. Market by product covers equipment and contrast agents.

To promote product usability and enhance the diagnostic experience of the machine operator, ultrasound system manufacturers are increasingly offering comprehensive solutions for ultrasound imaging in a single system. As it is being employed in all upcoming ultrasound technologies, contrast-enhanced ultrasound imaging is an emerging technique that has lately received approval for several new applications. The development of ultrasound modalities and agents specifically suited for contrast imaging by pharmaceutical firms, academic institutions, and ultrasound manufacturers is also anticipated to fuel segment growth throughout the forecast period.

Some of the leading players in the North America contrast enhanced ultrasound market include Lantheus Medical Imaging Inc, Bracco Diagnostic Inc, etc.

Lantheus Medical Imaging Inc is a subsidiary of Lantheus Holdings Inc and develops, manufactures, and commercializes diagnostic imaging agents and products for diagnosing conditions that affect the heart, brain, lungs, and other organs using echocardiography and nuclear imaging. The company’s major products include ultrasound contrast agents, inhalable and injectable radiopharmaceutical imaging agents, and technetium-based generators. Its products diagnose coronary artery disease, stroke, congestive heart failure, cancerous tumors and other diseases.

Furthermore, Lantheus Medical Imaging has a strong brand presence and has been operating in the US healthcare market for over 60 years. Lantheus’s established presence helps it attract and serve a diverse customer base and build customer confidence in its product portfolio. The company offers its products to radiologists, internal medicine physicians, cardiologists, nuclear physicians, sonographers, and technologists. The company is headquartered in North Billerica, Massachusetts, United States.

DEFINITY from Lantheus Medical Imaging is a cardiovascular ultrasound enhancement agent used as an injectable during a contrast enhanced ultrasound imaging. The liquid product is composed of lipid-coated, octa-fluoro propane gas-filled echogenic microbubbles. DEFINITY enhances clinicians’ view of the left ventricle of the heart to aid diagnosis during an echocardiogram.

Report Synopsis

Report Scope

Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed End-User, Product, and Type
Countries Analyzed United States and Canada
Companies Analyzed

GE Healthcare, Bracco Diagnostic Inc, Trivitron Healthcare Pvt Ltd, Koninklijke Philips NV, Daiichi Sankyo Company Limited, Siemens Healthineers AG, Lantheus Medical Imaging Inc, Shenzhen Mindray Bio-Medical Electronics Co Ltd, NanoPET Pharma GmbH, Bayer AG, Taejoon Pharm Co Ltd, Sanochemia Pharmazeutika GmbH

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • SURGING PREVALENCE OF CHRONIC DISEASES
        • HEALTH PRACTITIONERS PREFER CONTRAST-ENHANCED ULTRASOUND IMAGING
        • TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSIS
      • KEY RESTRAINTS
        • NON-UNIFORMITY OF CONTRAST AGENTS
        • DIFFICULTY IN ADOPTION IN THE CURRENT HEALTHCARE SYSTEM
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON CONTRAST ENHANCED ULTRASOUND MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
        • COST EFFICIENCY
        • PRODUCT FEATURES
        • END-USE
      • REGULATORY FRAMEWORK
    2. MARKET BY PRODUCT
      • EQUIPMENT
      • CONTRAST AGENT
    3. MARKET BY TYPE
      • NON-TARGETED
      • TARGETED
    4. MARKET BY END-USER
      • HOSPITALS
      • CLINICS
      • AMBULATORY DIAGNOSTIC CENTERS
    5. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • BAYER AG
        • BRACCO DIAGNOSTIC INC
        • DAIICHI SANKYO COMPANY LIMITED
        • GE HEALTHCARE
        • KONINKLIJKE PHILIPS NV
        • LANTHEUS MEDICAL IMAGING INC
        • NANOPET PHARMA GMBH
        • SANOCHEMIA PHARMAZEUTIKA GMBH
        • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
        • SIEMENS HEALTHINEERS AG
        • TAEJOON PHARM
        • TRIVITRON HEALTHCARE

    LIST OF TABLES

    TABLE 1: NORTH AMERICA MARKET SNAPSHOT – CONTRAST ENHANCED ULTRASOUND

    TABLE 2: EXAMPLES OF CURRENT CLINICAL ULTRASOUND CONTRAST AGENTS

    TABLE 3: EXAMPLES OF EMERGING ULTRASOUND MICROBUBBLES-BASED TECHNIQUES

    TABLE 4: REGULATORY FRAMEWORK

    TABLE 5: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 6: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 7: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 8: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 9: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 10: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 11: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 12: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 13: LEADING PLAYERS OPERATING IN NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET

    TABLE 14: LIST OF MERGERS & ACQUISITIONS

    TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES   

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: VALUE CHAIN ANALYSIS

    FIGURE 6: KEY BUYING CRITERIA

    FIGURE 7: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021

    FIGURE 8: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY EQUIPMENT, 2022-2030 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY CONTRAST AGENT, 2022-2030 (IN $ MILLION)

    FIGURE 10: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021

    FIGURE 11: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY NON-TARGETED, 2022-2030 (IN $ MILLION)

    FIGURE 12: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY TARGETED, 2022-2030 (IN $ MILLION)

    FIGURE 13: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

    FIGURE 14: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY CLINICS, 2022-2030 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY AMBULATORY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)

    FIGURE 17: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 18: UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 19: CANADA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)       

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY PRODUCT
      • EQUIPMENT
      • CONTRAST AGENT
    2. MARKET BY TYPE
      • NON-TARGETED
      • TARGETED
    3. MARKET BY END-USER
      • HOSPITALS
      • CLINICS
      • AMBULATORY DIAGNOSTIC CENTERS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type